Satya S. Pathi
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
42
Citations
1,710
Est. group size
—
Recurring co-author estimate
Active years
17
Publishing since 2010
Typically publishes in teams of ~10 · 0% small-team papers (≤3 authors) · across 11 venues
- Abstract PS4-08-15: Towards Personalized Medicine - Patient-Derived Breast Tumor Grafts as Predictors of Relapse and Response to Therapy: Final Results
Clinical Cancer Research · 2026
- AAA ATPase TRIP13 is overexpressed in prostate cancer and promotes tumor progression
Translational Oncology · 2026
- Data from Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
2023
- Supplementary Figure 3 from Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
2023
- Supplementary Figure 2 from Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
2023
- Supplementary Figure 1 from Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
2023
- Supplementary Figure 3 from Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
2023
- Supplementary Figure 2 from Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
2023
- Supplementary Figure 1 from Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
2023
- Data from Induction of the Transcriptional Repressor ZBTB4 in Prostate Cancer Cells by Drug-Induced Targeting of MicroRNA-17-92/106b-25 Clusters
2023
- A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
Nature Cancer · 2022
- A breast cancer patient-derived xenograft and organoid platform for drug discovery and precision oncology
bioRxiv (Cold Spring Harbor Laboratory) · 2021
- Abstract 606: Pkm2 activation modulates the tumor-immune microenvironment and enhances response to checkpoint inhibitors in preclinical solid tumor models
Cancer Research · 2021
- Abstract 1959: CDK9 inhibition combined with hypomethylating agents target MCL-1 dependency in MDS and AML
Cancer Research · 2021
- CCDC 2078682: Experimental Crystal Structure Determination
The Cambridge Structural Database · 2021
- Cancer Research×5
- The Prostate×2
- Nature Cancer×1
- Oncogene×1
- Molecular Cancer Research×1
- Dario Palmieri
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Inhan Lee
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Jia Shen
Biochemistry, Genetics and Molecular Biology · Indiana University
- You Li
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jie Xu
Biochemistry, Genetics and Molecular Biology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile